Breaking News, Promotions & Moves

Woodstock Sterile Solutions Appoints Quality SVP

Sheila Moran has 30 years experience serving in management roles in quality assurance, facility compliance, validation, manufacturing/ops and R&D.

By: Kristin Brooks

Managing Editor, Contract Pharma

Woodstock Sterile Solutions, a blow-fill-seal (BFS) contract development and manufacturing organization (CDMO), has appointed pharmaceutical industry veteran Sheila Moran as company’s newly created role of Senior Vice President of Quality.
 
“As the global leader in developing and supplying advanced aseptic blow-fill-seal [BFS] products for healthcare companies, our customers depend on us to ensure that we follow and implement the highest quality standards in our manufacturing processes. The Senior Vice President of Quality plays a vitally important role at Woodstock Sterile Solutions, and Sheila is joining our team at the right time, as we are continuing to grow to meet the increased demand for BFS solutions. I look forward to Sheila using her experience and knowledge to expand on the industry-leading quality programs that we have in place here,” says Paul Josephs, CEO of Woodstock Sterile Solutions.
 

Moran has worked in the pharmaceutical industry for more than 30 years, serving in management roles in quality assurance, facility compliance, validation, manufacturing/operations and research and development. Prior to joining Woodstock Sterile Solutions, she served as the Vice President of Quality for Xeris Pharmaceuticals, where she was responsible for the strategy, direction and execution of all aspects of the company’s quality initiatives, quality control and training programs.
 
“I am thrilled to be joining Woodstock Sterile Solutions, which has built a reputation as a strong organization within the pharmaceutical industry,” says Moran. “This is a fast-growing company, and as you add new people and more equipment, it is critical to maintain a high level of focus on quality assurance. I am excited to get started and to build programs that will help us continue to deliver for our customers.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters